Anagram Therapeutics Inc.
PrivateLast Round
Early Funding
May 7, 2026
Total Funding Raised
$251.8M
Momentum Score
75 /100
Company Overview
Anagram Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel, orally delivered enzyme therapeutics for the treatment of serious diseases caused by malabsorption syndromes and nutrient metabolism disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anagram Therapeutics Inc. Comps
Public and private peers based on sector, stage, and business model.
Anagram Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 7, 2026 | ||||
| Grant | Apr 4, 2023 | ||||
| Grant | Sep 10, 2021 | ||||
| Grant | Feb 12, 2020 | ||||
| VC Round | Jun 29, 2017 |
Key People
Founding team and executive leadership
Anagram Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Cystic Fibrosis Foundation | Early Funding, Grant |
| Blackstone Life Sciences | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 7, 2026
$250M raised, led by Blackstone Life Sciences.
- Feb 1, 2026
Monthly visitors grew 75% MoM.
Anagram Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Anagram Therapeutics Inc.'s valuation, stock price, and market status.
